Publication | Open Access
Evolution of Survival Impact of Molecular Target Agents in Patients with Advanced Hepatocellular Carcinoma
50
Citations
26
References
2021
Year
The availability of multiple MTAs had steadily improved the prognosis of patients with advanced HCC patients, particularly advanced-stage HCC patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1